72 related articles for article (PubMed ID: 23463709)
1. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
[TBL] [Abstract][Full Text] [Related]
2. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
; Young J; Psichogiou M; Meyer L; Ayayi S; Grabar S; Raffi F; Reiss P; Gazzard B; Sharland M; Gutierrez F; Obel N; Kirk O; Miro JM; Furrer H; Castagna A; De Wit S; Muñoz J; Kjaer J; Grarup J; Chêne G; Bucher H
PLoS Med; 2012; 9(3):e1001194. PubMed ID: 22448150
[TBL] [Abstract][Full Text] [Related]
3. Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women.
Travassos AG; Netto E; Xavier-Souza E; Nóbrega I; Adami K; Timbó M; Abbehusen K; Fernandes S; Duran C; Haguihara T; Ferreira F; Brites C
PLoS One; 2017; 12(10):e0185423. PubMed ID: 28981551
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors for anogenital HPV infection and neoplasia among women living with HIV in China.
Duan R; Zhang H; Wu A; Li C; Li L; Xu X; Qiao Y; Zhao F; Clifford G
Sex Transm Infect; 2022 Jun; 98(4):247-254. PubMed ID: 34187906
[TBL] [Abstract][Full Text] [Related]
5. Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance Among Women in Senegal, West Africa.
Li Z; Winer RL; Ba S; Sy MP; Lin J; Feng Q; Gottlieb GS; Salif Sow P; Kiviat NB; Hawes SE
J Infect Dis; 2023 Apr; 227(9):1088-1096. PubMed ID: 36314598
[TBL] [Abstract][Full Text] [Related]
6. Depletion and activation of mucosal CD4 T cells in HIV infected women with HPV-associated lesions of the cervix uteri.
Mbuya W; Mcharo R; Mhizde J; Mnkai J; Mahenge A; Mwakatima M; Mwalongo W; Chiwerengo N; Hölscher M; Lennemann T; Saathoff E; Rwegoshora F; Torres L; Kroidl A; Geldmacher C; Held K; Chachage M
PLoS One; 2020; 15(10):e0240154. PubMed ID: 33007050
[TBL] [Abstract][Full Text] [Related]
7. Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure.
Lodi S; Phillips A; Fidler S; Hawkins D; Gilson R; McLean K; Fisher M; Post F; Johnson AM; Walker-Nthenda L; Dunn D; Porter K;
PLoS One; 2013; 8(9):e75608. PubMed ID: 24086588
[TBL] [Abstract][Full Text] [Related]
8. High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysis.
Caicedo-Martínez M; Fernández-Deaza G; Ordóñez-Reyes C; Olejua P; Nuche-Berenguer B; Mello MB; Murillo R
Int J STD AIDS; 2021 Dec; 32(14):1278-1289. PubMed ID: 34488503
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
Chetty-Sebastian D; Assounga AG
BMC Cancer; 2023 Sep; 23(1):830. PubMed ID: 37670247
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population.
Sosso SM; Tchouaket MCT; Fokam J; Simo RK; Semengue ENJ; Sando Z; Torimiro J; Tiga A; Lobe EE; Ambada G; Nange A; Nka AD; Chenwi C; Abba A; Ka'e AC; Fainguem N; Zam MKN; Yagai B; Billong SC; Colizzi V; Ndjolo A
J Public Health Afr; 2023 Oct; 14(9):2334. PubMed ID: 37942060
[TBL] [Abstract][Full Text] [Related]
11. Confronting the human papillomavirus-HIV intersection: Cervical cytology implications for Kenyan women living with HIV.
Kangethe JM; Gichuhi S; Odari E; Pintye J; Mutai K; Abdullahi L; Maiyo A; Mureithi MW
South Afr J HIV Med; 2023; 24(1):1508. PubMed ID: 37928501
[TBL] [Abstract][Full Text] [Related]
12. HIV Infection and the Risk of World Health Organization-Defined Sudden Cardiac Death.
Freiberg MS; Duncan MS; Alcorn C; Chang CH; Kundu S; Mumpuni A; Smith EK; Loch S; Bedigian A; Vittinghoff E; So-Armah K; Hsue PY; Justice AC; Tseng ZH
J Am Heart Assoc; 2021 Sep; 10(18):e021268. PubMed ID: 34493058
[TBL] [Abstract][Full Text] [Related]
13. HIV infection and COVID-19: risk factors for severe disease.
Etienne N; Karmochkine M; Slama L; Pavie J; Batisse D; Usubillaga R; Letembet VA; Brazille P; Canouï E; Slama D; Joumaa H; Canoui-Poitrine F; Segaux L; Weiss L; Viard JP; Salmon D;
AIDS; 2020 Oct; 34(12):1771-1774. PubMed ID: 32773476
[TBL] [Abstract][Full Text] [Related]
14. Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer.
Odeny TA; Lurain K; Strauss J; Fling SP; Sharon E; Wright A; Martinez-Picado J; Moran T; Gulley JL; Gonzalez-Cao M; Uldrick TS; Yarchoan R; Ramaswami R
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 37935055
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of human papillomavirus in ocular surface squamous neoplasia in HIV positive and negative patients in a South African population.
Odendaal LN; Andreae C; Sanderson-November M; Zaharie D; Smit DP
Infection; 2024 May; ():. PubMed ID: 38724852
[TBL] [Abstract][Full Text] [Related]
16. Incidence of oncogenic HPV infection in women with and without mental illness: A population-based cohort study in Sweden.
Herweijer E; Hu K; Wang J; Lu D; Sparén P; Adami HO; Valdimarsdóttir U; Sundström K; Fang F
PLoS Med; 2024 Mar; 21(3):e1004372. PubMed ID: 38527071
[TBL] [Abstract][Full Text] [Related]
17. The association between HIV infection and cervical cancer presentation and survival in Uganda.
Wu ES; Urban RR; Krantz EM; Mugisha NM; Nakisige C; Schwartz SM; Gray HJ; Casper C
Gynecol Oncol Rep; 2020 Feb; 31():100516. PubMed ID: 31886403
[TBL] [Abstract][Full Text] [Related]
18. Colposcopic Study of Lower Genital Tract Infections in HIV-Positive Women on Antiretroviral Therapy.
Badkur P; Singh KN; Ghanghoriya V
J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):471-7. PubMed ID: 27651648
[TBL] [Abstract][Full Text] [Related]
19. Relationship between HIV serostatus, CD4 count and rehospitalisation: Potential implications for health systems strengthening in South Africa.
Moodley Y; Tomita A
S Afr J Infect Dis; 2017; 32(1):23-28. PubMed ID: 28393071
[TBL] [Abstract][Full Text] [Related]
20. Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
McClymont E; Lee M; Raboud J; Coutlée F; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Harris M; Cohen J; Yudin MH; Wobeser W; Money D
Int J Gynaecol Obstet; 2020 Jul; 150(1):108-115. PubMed ID: 32342504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
